Senseonics Holdings, Inc. (SENS)
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Sector: Industrial Instruments For Measurement, Display, and Control
Industry: Medical - Devices
Senseonics Holdings, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 52.87M shares outstanding
USSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.
The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.
It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners.
The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Leadership
Brian Hansen
Chief Commercial Officer & Director
Francine R. Kaufman, M.D.
Chief Medical Officer and Director
Frederick (“Rick”) Sullivan
Chief Financial Officer, Secretary and Treasurer
Kenneth L. Horton
General Counsel & Corporate Development Advisor
Employees
117
Country
US
Sector
Healthcare
Website
senseonics.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Fiorentino Edward | Director | Grant/Award | 1.4K | $14.1K | Oct 1, 2026 |
 Prince Douglas S | Director | Grant/Award | 815 | $8.1K | Oct 1, 2026 |
 Steven Edelman | Director | Grant/Award | 1.3K | $12.9K | Oct 1, 2026 |
 ROEDER DOUGLAS A | Director | Grant/Award | 1.5K | $14.7K | Oct 1, 2026 |
| ROEDER DOUGLAS A | Director | Purchase | 14.0K | $125.3K | Aug 19, 2026 |
| Prince Douglas S | Director | Grant/Award | 1.5K | $8.1K | Jul 1, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Sessa Capital IM, L.P. · net of 13F· joint filing· may incl. warrants· filed Sep 2026 | 12.4M | 9.9% as filed | 13G |
Sessa Capital IM, L.P. | 4.4M | 8.4% | 13F |
BlackRock, Inc. | 2.8M | 5.3% | 13F |
ROBERT J. SMITH · may incl. warrants· filed Aug 2025 | 2.5M | 4.7% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | 3.4% | 13F |
Avidity Partners Management LP | 1.6M | 3.0% | 13F |
Sio Capital Management, LLC | 1.6M | 3.0% | 13F |
UBS Group AG | 1.5M | 2.8% | 13F |
 Goodnow Timothy T President and CEO, Director | 1.1M | 2.2% | FORM 4 |
GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 2.1% | 13F |
Insiders
- Fiorentino EdwardDirector
- Prince Douglas SDirector
- Steven EdelmanDirector
- ROEDER DOUGLAS ADirector
- Horton Kenneth LGC & Corp. Development Advisor
- Sullivan Frederick T.Chief Financial Officer
- Kaufman FrancineChief Medical Officer
- JAIN MukulChief Operating Officer
- Goodnow Timothy TPresident and CEO
- HANSEN BRIAN BChief Commercial Officer
based on 52.87M shares outstanding
US30d Avg
590.18K
60d Avg
646.20K
90d Avg
697.32K